These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 16904417

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Changes in weight with depot medroxyprogesterone acetate subcutaneous injection 104 mg/0.65 mL.
    Westhoff C, Jain JK, Milsom I, Ray A.
    Contraception; 2007 Apr; 75(4):261-7. PubMed ID: 17362703
    [Abstract] [Full Text] [Related]

  • 3. Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.
    Kaunitz AM, Darney PD, Ross D, Wolter KD, Speroff L.
    Contraception; 2009 Jul; 80(1):7-17. PubMed ID: 19501210
    [Abstract] [Full Text] [Related]

  • 4. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.
    Schlaff WD, Carson SA, Luciano A, Ross D, Bergqvist A.
    Fertil Steril; 2006 Feb; 85(2):314-25. PubMed ID: 16595206
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacist-administered subcutaneous depot medroxyprogesterone acetate: a pilot randomized controlled trial.
    Picardo C, Ferreri S.
    Contraception; 2010 Aug; 82(2):160-7. PubMed ID: 20654757
    [Abstract] [Full Text] [Related]

  • 9. Endometrial progesterone and estrogen receptors and bleeding disturbances in depot medroxyprogesterone acetate users.
    Sereepapong W, Chotnopparatpattara P, Taneepanichskul S, Markham R, Russell P, Fraser IS.
    Hum Reprod; 2004 Mar; 19(3):547-52. PubMed ID: 14998949
    [Abstract] [Full Text] [Related]

  • 10. Long-acting injectable contraception with depot medroxyprogesterone acetate.
    Kaunitz AM.
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1543-9. PubMed ID: 8178904
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Facts about injectable contraceptives: memorandum from a WHO meeting.
    Bull World Health Organ; 1982 May; 60(2):199-210. PubMed ID: 6213318
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.
    Clark MK, Sowers MR, Nichols S, Levy B.
    Fertil Steril; 2004 Dec; 82(6):1580-6. PubMed ID: 15589863
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pilot study of home self-administration of subcutaneous depo-medroxyprogesterone acetate for contraception.
    Cameron ST, Glasier A, Johnstone A.
    Contraception; 2012 May; 85(5):458-64. PubMed ID: 22079602
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
    Zhou J, Lei ZW, Lü JQ, Sun J, Xu XW.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.